Skip to main content
. 2020 Nov 24;21(23):8892. doi: 10.3390/ijms21238892

Figure 6.

Figure 6

Effects of the ataxic telangiectasia mutation (ATM)-specific inhibitor KU-55933 on bovine COCs: (A) PBEI% of bovine COCs with different concentrations of KU-55933 treatment for 22 h; (B) after bovine COCs were treated with 10 μM KU-55933 for 22 h, the oocytes at PBEI (“maturation”, green charts) and oocytes at GV (“immature”, purple charts) were collected, in order to detect the genes for oocyte quality evaluation and cell cycle. * indicates p < 0.05, ** indicates p < 0.01.